PANG Hanqing, SHANG Xiaoyu, WEI Ye, DING Shuwen, LIU Liang. Mechanism of Tongmai granules in treatment of stroke based on ultra-high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry and network pharmacology[J]. Journal of Clinical Medicine in Practice, 2022, 26(24): 13-19. DOI: 10.7619/jcmp.20223482
Citation: PANG Hanqing, SHANG Xiaoyu, WEI Ye, DING Shuwen, LIU Liang. Mechanism of Tongmai granules in treatment of stroke based on ultra-high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry and network pharmacology[J]. Journal of Clinical Medicine in Practice, 2022, 26(24): 13-19. DOI: 10.7619/jcmp.20223482

Mechanism of Tongmai granules in treatment of stroke based on ultra-high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry and network pharmacology

More Information
  • Received Date: November 20, 2022
  • Available Online: January 06, 2023
  • Objective 

    To explore the mechanisms of Tongmai granules in treatment of stroke based on ultra-high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UHPLC-QTOF-MS) and network pharmacology technology.

    Methods 

    The chemical compounds of Tongmai granules were identified by UHPLC-QTOF-MS approach. The compounds' targets and stroke-related targets were screened via TCMSP, TTD and PubMed databases. STRING database was used to construct the protein interaction network of key targets. DAVID database was used for Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis for key targets.

    Results 

    A total of 96 chemical components, such as salvianolic acid B, puerarin and ligustilide were identifiedfrom Tongmai granules. A total of 38 active compounds and 55 targets of Tongmai granules for stroke treatment were obtained. The core targets included prostaglandin-endoperoxide synthase 2 (PTGS2), nuclear factor kappa B (NFκB)as well as nuclear factor erythroid 2-related factor 2 (NRF2) and so on, and the key pathways mainly involved hypoxia-inducible factor-1 (HIF-1), tumor necrosis factor (TNF) and phosphatidylinositol 3-kinase (PI3K)-Akt and so on.

    Conclusion 

    Major active components such as salvianolic acid B, puerarin and ligustilide in Tongmai granules regulate HIF-1, TNF and PI3K-Akt signaling pathways by acting on PTGS2, NFκB and NRF2 and other targets to play an anti-stroke role.

  • [1]
    陈孝男, 杨爱琳, 赵亚楠, 等. 缺血性脑中风的发病机制及其常用治疗中药研究进展[J]. 中国中药杂志, 2019, 44(3): 422-432. doi: 10.19540/j.cnki.cjcmm.20180921.002
    [2]
    MA Q F, LI R, WANG L J, et al. Temporal trend and attributable risk factors of stroke burden in China, 1990-2019: an analysis for the Global Burden of Disease Study 2019[J]. Lancet Public Health, 2021, 6(12): e897-e906. doi: 10.1016/S2468-2667(21)00228-0
    [3]
    王陇德, 吉训明, 康德智, 等. 《中国卒中中心报告2020》概要[J]. 中国脑血管病杂志, 2021, 18(11): 737-743. https://www.cnki.com.cn/Article/CJFDTOTAL-NXGB202111001.htm
    [4]
    CYRANOSKI D. Why Chinese medicine is heading for clinics around the world[J]. Nature, 2018, 561(7724): 448-450. doi: 10.1038/d41586-018-06782-7
    [5]
    WANG F R, YANG X W, ZHANG Y, et al. Three new isoflavone glycosides from Tongmai granules[J]. J Asian Nat Prod Res, 2011, 13(4): 319-329. doi: 10.1080/10286020.2011.556090
    [6]
    张静. 通脉颗粒联合氯吡格雷及依折麦布治疗脑梗死临床观察[J]. 实用中医药杂志, 2021, 37(2): 287-288. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYAO202102073.htm
    [7]
    BAI F, HU N, YANG R, et al. Tongmai granules improve rat hippocampal injury by regulating TLR4/MyD88/AP-1 signaling pathway[J]. J Ethnopharmacol, 2022, 285: 114874. doi: 10.1016/j.jep.2021.114874
    [8]
    张颖, 李丹, 韩笑, 等. 通脉颗粒活血通脉功效的指征药效成分研究[J]. 世界科学技术-中医药现代化, 2015, 17(7): 1398-1404. https://www.cnki.com.cn/Article/CJFDTOTAL-SJKX201507015.htm
    [9]
    于海永, 杜振元. 通脉颗粒联合丁苯酞治疗急性脑梗死的临床研究[J]. 现代药物与临床, 2020, 35(2): 252-257. https://www.cnki.com.cn/Article/CJFDTOTAL-GWZW202002013.htm
    [10]
    MEIM X D, CAO Y F, CHE Y Y, et al. Danshen: a phytochemical and pharmacological overview[J]. Chin J Nat Med, 2019, 17(1): 59-80.
    [11]
    CHEN Z J, ZHANG C, GAO F, et al. A systematic review on the rhizome of Ligusticum Chuanxiong Hort. (Chuanxiong)[J]. Food Chem Toxicol, 2018, 119: 309-325. doi: 10.1016/j.fct.2018.02.050
    [12]
    WANG S G, ZHANG S M, WANG S P, et al. A comprehensive review on Pueraria: insights on its chemistry and medicinal value[J]. Biomed Pharmacother, 2020, 131: 110734.
    [13]
    孙小鑫, 苗青, 王瑞海, 等. 丹参-葛根药对成分、药理及临床应用的研究进展[J]. 世界科学技术-中医药现代化, 2020, 22(12): 4308-4313. https://www.cnki.com.cn/Article/CJFDTOTAL-SJKX202012032.htm
    [14]
    CAPRIO F Z, SOROND F A. Cerebrovascular disease: primary and secondary stroke prevention[J]. Med Clin North Am, 2019, 103(2): 295-308.
    [15]
    武丽芳, 胥向红, 高晓嵘, 等. 二氧化氮与缺血性脑中风和血管性痴呆的相关性研究[J]. 实用临床医药杂志, 2015, 19(17): 18-20. doi: 10.7619/jcmp.201517006
    [16]
    周敏, 江丰, 崔远武, 等. 张伯礼教授辨治中风病经验[J]. 天津中医药, 2015, 32(9): 513-516. https://www.cnki.com.cn/Article/CJFDTOTAL-TJZY201509001.htm
    [17]
    FAN Y, LUO Q P, WEI J J, et al. Mechanism of salvianolic acid B neuroprotection against ischemia/reperfusion induced cerebral injury[J]. Brain Res, 2018, 1679: 125-133.
    [18]
    SUBEDI L, GAIRE B P. Tanshinone IIA: a phytochemical as a promising drug candidate for neurodegenerative diseases[J]. Pharmacol Res, 2021, 169: 105661.
    [19]
    WANG L, XIONG X X, ZHANG X, et al. Sodium tanshinone IIA sulfonate protects against cerebral ischemia-reperfusion injury by inhibiting autophagy and inflammation[J]. Neuroscience, 2020, 441: 46-57.
    [20]
    MIAO Q, WANG R H, SUN X X, et al. Combination of puerarin and tanshinone IIA alleviates ischaemic stroke injury in rats via activating the Nrf2/ARE signalling pathway[J]. Pharm Biol, 2022, 60(1): 1022-1031.
    [21]
    SCHREIHOFER D A, OPPONG-GYEBI A. Genistein: mechanisms of action for a pleiotropic neuroprotective agent in stroke[J]. Nutr Neurosci, 2019, 22(6): 375-391.
    [22]
    HAN L, LIU D L, ZENG Q K, et al. The neuroprotective effects and probable mechanisms of Ligustilide and its degradative products on intracerebral hemorrhage in mice[J]. Int Immunopharmacol, 2018, 63: 43-57.
    [23]
    HE Q Y, MA Y Z, LIU J, et al. Biological functions and regulatory mechanisms of hypoxia-inducible factor-1α in ischemic stroke[J]. Front Immunol, 2021, 12: 801985.
    [24]
    侯兵兵, 张本平, 毛森林, 等. 进展性卒中危险因素的研究现状[J]. 临床神经病学杂志, 2020, 33(2): 146-151. https://www.cnki.com.cn/Article/CJFDTOTAL-LCSJ202002025.htm
    [25]
    YUAN Q, WANG F J, JIA Z Z, et al. Xueshuantong injection combined with Salvianolate lyophilized injection improves the synaptic plasticity against focal cerebral ischemia/reperfusion injury in rats through PI3K/AKT/mTOR and RhoA/ROCK pathways[J]. Brain Res, 2022, 1787: 147923.
    [26]
    EYILETEN C, SHARIF L, WICIK Z, et al. The relation of the brain-derived neurotrophic factor with microRNAs in neurodegenerative diseases and ischemic stroke[J]. Mol Neurobiol, 2021, 58(1): 329-347.
    [27]
    张斯时, 张艳. 环氧合酶-1和环氧合酶-2基因多态性与阿司匹林抵抗的相关性研究[J]. 中国临床药理学杂志, 2015, 31(17): 1724-1726. https://www.cnki.com.cn/Article/CJFDTOTAL-GLYZ201517008.htm
  • Cited by

    Periodical cited type(1)

    1. 许佳慧,刘玉红,黄志芳,刘云华,陈燕,胥亭亭,易进海. 通脉制剂质量一致性评价. 中成药. 2025(03): 709-716 .

    Other cited types(0)

Catalog

    Article views (274) PDF downloads (24) Cited by(1)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return